Eintrag weiter verarbeiten
Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects
Gespeichert in:
Zeitschriftentitel: | Kanzo |
---|---|
Personen und Körperschaften: | , , , , , , , , |
In: | Kanzo, 53, 2012, 2, S. 69-77 |
Format: | E-Article |
Sprache: | Japanisch |
veröffentlicht: |
Japan Society of Hepatology
|
Schlagwörter: |
author_facet |
Ozeki, Itaru Karino, Yoshiyasu Toyota, Joji Takahashi, Shoichi Kawakami, Yoshiiku Chayama, Kazuaki Akuta, Norio Suzuki, Fumitaka Kumada, Hiromitsu Ozeki, Itaru Karino, Yoshiyasu Toyota, Joji Takahashi, Shoichi Kawakami, Yoshiiku Chayama, Kazuaki Akuta, Norio Suzuki, Fumitaka Kumada, Hiromitsu |
---|---|
author |
Ozeki, Itaru Karino, Yoshiyasu Toyota, Joji Takahashi, Shoichi Kawakami, Yoshiiku Chayama, Kazuaki Akuta, Norio Suzuki, Fumitaka Kumada, Hiromitsu |
spellingShingle |
Ozeki, Itaru Karino, Yoshiyasu Toyota, Joji Takahashi, Shoichi Kawakami, Yoshiiku Chayama, Kazuaki Akuta, Norio Suzuki, Fumitaka Kumada, Hiromitsu Kanzo Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects Hepatology |
author_sort |
ozeki, itaru |
spelling |
Ozeki, Itaru Karino, Yoshiyasu Toyota, Joji Takahashi, Shoichi Kawakami, Yoshiiku Chayama, Kazuaki Akuta, Norio Suzuki, Fumitaka Kumada, Hiromitsu 0451-4203 1881-3593 Japan Society of Hepatology Hepatology http://dx.doi.org/10.2957/kanzo.53.69 Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects Kanzo |
doi_str_mv |
10.2957/kanzo.53.69 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjk1Ny9rYW56by41My42OQ |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjk1Ny9rYW56by41My42OQ |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
imprint |
Japan Society of Hepatology, 2012 |
imprint_str_mv |
Japan Society of Hepatology, 2012 |
issn |
0451-4203 1881-3593 |
issn_str_mv |
0451-4203 1881-3593 |
language |
Japanese |
mega_collection |
Japan Society of Hepatology (CrossRef) |
match_str |
ozeki2012telaprevirincombinationwithpeginterferonalfa2bandribavirintherapyforgenotype1japanesechronichcvpatientsimpactonadherenceandantiviraleffects |
publishDateSort |
2012 |
publisher |
Japan Society of Hepatology |
recordtype |
ai |
record_format |
ai |
series |
Kanzo |
source_id |
49 |
title |
Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_unstemmed |
Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_full |
Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_fullStr |
Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_full_unstemmed |
Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_short |
Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_sort |
telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 japanese chronic hcv patients: impact on adherence and antiviral effects |
topic |
Hepatology |
url |
http://dx.doi.org/10.2957/kanzo.53.69 |
publishDate |
2012 |
physical |
69-77 |
description |
|
container_issue |
2 |
container_start_page |
69 |
container_title |
Kanzo |
container_volume |
53 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792324749619101699 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T11:54:39.064Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Telaprevir+in+combination+with+peginterferon+alfa-2b+and+ribavirin+therapy+for+genotype+1+Japanese+chronic+HCV+patients%3A+Impact+on+adherence+and+antiviral+effects&rft.date=2012-01-01&genre=article&issn=1881-3593&volume=53&issue=2&spage=69&epage=77&pages=69-77&jtitle=Kanzo&atitle=Telaprevir+in+combination+with+peginterferon+alfa-2b+and+ribavirin+therapy+for+genotype+1+Japanese+chronic+HCV+patients%3A+Impact+on+adherence+and+antiviral+effects&aulast=Kumada&aufirst=Hiromitsu&rft_id=info%3Adoi%2F10.2957%2Fkanzo.53.69&rft.language%5B0%5D=jpn |
SOLR | |
_version_ | 1792324749619101699 |
author | Ozeki, Itaru, Karino, Yoshiyasu, Toyota, Joji, Takahashi, Shoichi, Kawakami, Yoshiiku, Chayama, Kazuaki, Akuta, Norio, Suzuki, Fumitaka, Kumada, Hiromitsu |
author_facet | Ozeki, Itaru, Karino, Yoshiyasu, Toyota, Joji, Takahashi, Shoichi, Kawakami, Yoshiiku, Chayama, Kazuaki, Akuta, Norio, Suzuki, Fumitaka, Kumada, Hiromitsu, Ozeki, Itaru, Karino, Yoshiyasu, Toyota, Joji, Takahashi, Shoichi, Kawakami, Yoshiiku, Chayama, Kazuaki, Akuta, Norio, Suzuki, Fumitaka, Kumada, Hiromitsu |
author_sort | ozeki, itaru |
container_issue | 2 |
container_start_page | 69 |
container_title | Kanzo |
container_volume | 53 |
description | |
doi_str_mv | 10.2957/kanzo.53.69 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjk1Ny9rYW56by41My42OQ |
imprint | Japan Society of Hepatology, 2012 |
imprint_str_mv | Japan Society of Hepatology, 2012 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
issn | 0451-4203, 1881-3593 |
issn_str_mv | 0451-4203, 1881-3593 |
language | Japanese |
last_indexed | 2024-03-01T11:54:39.064Z |
match_str | ozeki2012telaprevirincombinationwithpeginterferonalfa2bandribavirintherapyforgenotype1japanesechronichcvpatientsimpactonadherenceandantiviraleffects |
mega_collection | Japan Society of Hepatology (CrossRef) |
physical | 69-77 |
publishDate | 2012 |
publishDateSort | 2012 |
publisher | Japan Society of Hepatology |
record_format | ai |
recordtype | ai |
series | Kanzo |
source_id | 49 |
spelling | Ozeki, Itaru Karino, Yoshiyasu Toyota, Joji Takahashi, Shoichi Kawakami, Yoshiiku Chayama, Kazuaki Akuta, Norio Suzuki, Fumitaka Kumada, Hiromitsu 0451-4203 1881-3593 Japan Society of Hepatology Hepatology http://dx.doi.org/10.2957/kanzo.53.69 Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects Kanzo |
spellingShingle | Ozeki, Itaru, Karino, Yoshiyasu, Toyota, Joji, Takahashi, Shoichi, Kawakami, Yoshiiku, Chayama, Kazuaki, Akuta, Norio, Suzuki, Fumitaka, Kumada, Hiromitsu, Kanzo, Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects, Hepatology |
title | Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_full | Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_fullStr | Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_full_unstemmed | Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_short | Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
title_sort | telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 japanese chronic hcv patients: impact on adherence and antiviral effects |
title_unstemmed | Telaprevir in combination with peginterferon alfa-2b and ribavirin therapy for genotype 1 Japanese chronic HCV patients: Impact on adherence and antiviral effects |
topic | Hepatology |
url | http://dx.doi.org/10.2957/kanzo.53.69 |